Jane Street’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $370K | Sell |
96,683
-81,427
| -46% | -$312K | ﹤0.01% | 4062 |
|
|
2025
Q1 | $1.02M | Buy |
+178,110
| New | +$1.02M | ﹤0.01% | 3028 |
|
|
2024
Q4 | – | Sell |
-23,731
| Closed | -$128K | – | 5782 |
|
|
2024
Q3 | $128K | Sell |
23,731
-69,415
| -75% | -$374K | ﹤0.01% | 5395 |
|
|
2024
Q2 | $308K | Buy |
+93,146
| New | +$308K | ﹤0.01% | 4996 |
|
|
2024
Q1 | – | Sell |
-68,327
| Closed | -$240K | – | 5719 |
|
|
2023
Q4 | $240K | Sell |
68,327
-64,106
| -48% | -$225K | ﹤0.01% | 4854 |
|
|
2023
Q3 | $885K | Buy |
132,433
+77,785
| +142% | +$520K | ﹤0.01% | 3042 |
|
|
2023
Q2 | $458K | Sell |
54,648
-214,882
| -80% | -$1.8M | ﹤0.01% | 3835 |
|
|
2023
Q1 | $2.68M | Buy |
269,530
+206,348
| +327% | +$2.05M | ﹤0.01% | 1731 |
|
|
2022
Q4 | $440K | Buy |
+63,182
| New | +$440K | ﹤0.01% | 3541 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 5701 |
|
|
2022
Q2 | – | Sell |
-66,398
| Closed | -$295K | – | 5475 |
|
|
2022
Q1 | $295K | Sell |
66,398
-80,858
| -55% | -$359K | ﹤0.01% | 4332 |
|
|
2021
Q4 | $589K | Buy |
147,256
+93,774
| +175% | +$375K | ﹤0.01% | 3285 |
|
|
2021
Q3 | $469K | Buy |
53,482
+40,240
| +304% | +$353K | ﹤0.01% | 3496 |
|
|
2021
Q2 | $150K | Sell |
13,242
-6,203
| -32% | -$70.3K | ﹤0.01% | 4593 |
|
|
2021
Q1 | $231K | Sell |
19,445
-61,115
| -76% | -$726K | ﹤0.01% | 4155 |
|
|
2020
Q4 | $553K | Buy |
80,560
+63,051
| +360% | +$433K | ﹤0.01% | 2660 |
|
|
2020
Q3 | $130K | Sell |
17,509
-114,081
| -87% | -$847K | ﹤0.01% | 3380 |
|
|
2020
Q2 | $549K | Buy |
+131,590
| New | +$549K | ﹤0.01% | 2449 |
|
|
2017
Q4 | – | Sell |
-10,961
| Closed | -$79K | – | 3022 |
|
|
2017
Q3 | $79K | Buy |
+10,961
| New | +$79K | ﹤0.01% | 2756 |
|